Bifidobacterium longum subsp. infantis BLI-02

1 of 17 products in this brand
Bifidobacterium longum subsp. infantis BLI-02 is a product with benefits in blood glucose management, stimulating the immune system, antioxidant properties, and anti-aging effects. Labeling claims emphasize non-toxicity, non-hazardousness, and biodegradability. The production process includes fermentation, centrifuging, freeze-drying, and packaging. The end uses for this product are primarily dietary supplements.

Ingredient Name: Bifidobacterium Infantis

Functions: Probiotic

Labeling Claims: Biodegradable, Halal, Kosher, Non-Hazardous, Non-Toxic

Certifications & Compliance: EFSA (European Food Safety Authority) Certified, FDA Compliant

Benefit Claims (Health): Anti-Aging, Antioxidant Properties, Blood Glucose Management, Stimulates Immune System

Ask Pharm-Rx Chemical Corp. Questions

Mark Bostel avatar
Message our experts with questions
Mark Bostel avatar

Mark Bostel

Please reach out to me with any questions, I am happy to assist you in finding the right product or learning more about our storefront

Enhanced TDS

Identification & Functionality

Features & Benefits

Applications & Uses

Properties

Physical Form
Appearance
White to light brown color powder
Microbiological Values
ValueUnitsTest Method / Conditions
Yeast & Molds Countmax. 100cfu/gTaiwan Food and Drug Administration ( TFDA ) method
Staphylococcus AureusNegativecfu/gTaiwan Food and Drug Administration ( TFDA ) method
SalmonellaNegativecfu/gTaiwan Food and Drug Administration ( TFDA ) method
Listeria MonocytogenesNegativecfu/gTaiwan Food and Drug Administration ( TFDA ) method
Eschericha ColiNegativecfu/gTaiwan Food and Drug Administration ( TFDA ) method
ColiformsNegativecfu/gTaiwan Food and Drug Administration ( TFDA ) method
Specifications
ValueUnitsTest Method / Conditions
Water Activitymax. 0.25awTaiwan Food and Drug Administration ( TFDA ) method
Viable Cell Countsmin. 2.0 × 10¹¹cfu/gTaiwan Food and Drug Administration ( TFDA ) method
Moisture Contentmax. 7%Taiwan Food and Drug Administration ( TFDA ) method

Regulatory & Compliance

Certifications & Compliance
FDA Disclaimer

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Technical Details & Test Data

Product Characteristics

High Gastric Acid and Bile Tolerance:

BLI-02 remained high bioavailability in the simulated environment with Gastric Acid and Bile for 7 hours

Bioflag Bifidobacterium longum subsp. infantis BLI-02 - Product Characteristics - 1

Strong Colonization on Caco-2 Intestine Cells:

BLI-02 highly adheres to Caco-2 intestine cells

Bioflag Bifidobacterium longum subsp. infantis BLI-02 - Product Characteristics - 1

Human clinical trial: 38 Patients with stages 3-5 CKD supplemented with two capsules containing 2.5 billion FU of PRONULIFE® RenaProtect (BLI-02, TYCA06, VDD088) daily for 6 months:

After the 6-month treatment, taking probiotics improved kidney’s function and failure:

Bioflag Bifidobacterium longum subsp. infantis BLI-02 - Product Characteristics - 1

RenaProtect helps improve HbA1c level, stabilizing blood sugar:

Bioflag Bifidobacterium longum subsp. infantis BLI-02 - Product Characteristics - 1

Anti-Oxidant:

Strong ability to eliminate DPPH free radicals

Bioflag Bifidobacterium longum subsp. infantis BLI-02 - Product Characteristics - 1

 

 

 

Packaging & Availability

Packaging Type
Packaging Information

1kg a bag with nitrogen filling and vacuum packing

Storage & Handling

Shelf Life
24 months
Stability Test

BLI-02 remains stable at 4°C and 25°C for 24 months:

Bioflag Bifidobacterium longum subsp. infantis BLI-02 - Stability Test - 1

BLI-02  remains stable at -20°C for 36 months:

Bioflag Bifidobacterium longum subsp. infantis BLI-02 - Stability Test - 2